NuvOx to Present at Various Bio Forums in JPM Week Tucson, AZ, January 7, 2022
Tucson, AZ, January 7, 2022 – NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat...
top of page
The latest from NuvOx
Search
Oct 15, 2021
NuvOx Pharma Receives Phase I STTR Grant from NINDS for Preclinical Studies in Stroke
Tucson, AZ, October 12, 2021 --(PR.com)-- NuvOx Pharma, a Tucson based biotechnology company, has received a $478,000 NIH Phase I Small...
Sep 9, 2021
NuvOx Pharma Generates Positive Preclinical Data Showing NanO2TM Boosts Efficacy of Immunotherapy
Tucson, AZ, September 09, 2021 --(PR.com)-- NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has generated positive...
Jul 29, 2021
NuvOx Pharma Receives FDA Allowance to Proceed with Phase II Clinical Trial of NanO2TM
Tucson, AZ, July 29, 2021 --(PR.com)-- NuvOx Pharma, a Tucson-based biopharmaceutical company, has received notice from the FDA that they...
Jul 23, 2021
NuvOx Pharma Announces Issuance of New Patent Covering a New Method of Treating Cancer
Tucson, AZ, July 23, 2021 --(PR.com)-- NuvOx Pharma, a privately-held clinical-stage biotechnology company based in Tucson, Arizona, has...
May 27, 2021
Tucson's NuvOx adds plant to make drugs in-house
A tandem of homegrown Tucson drug-development companies plans to make its own drugs for testing at a new manufacturing plant — and...
Apr 30, 2021
NuvOx Completes Construction of Expanded Manufacturing Facility
A new GMP production facility including an ISO 5 cleanroom has been constructed and has initiated operations. Click here to read more...
Dec 28, 2020
NuvOx Pharma Announces Appointment of Jon S. Saxe to Its Board of Directors
"We are honored and excited to have Jon Saxe join our board," said Evan Unger MD, President and CEO of NuvOx. "His broad knowledge of the...
Jul 15, 2020
Hunniwell Lake Ventures Spotlights NuvOx
Hunniwell Lake Ventures interviews NuvOx Co-founder and CEO, Evan Unger MD.
Jun 29, 2020
Health Canada Allows Phase IIa Clinical Trial in COVID-19 Patients with Respiratory Failure
Health Canada allows a Phase IIa Trial in COVID-19 patients with Respiratory Failure
Dec 7, 2019
NuvOx Expands Production Line
NuvOx Pharma is breaking ground on an addition to its manufacturing facility. Read full story
Feb 28, 2019
NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial
Positive results of NuvOx Pharma’s NanO2 (DDFPe) in the treatment of stroke have been published at the International Stroke Conference. A...
Oct 18, 2017
NuvOx Wins TechConnect Defense Innovation Award
NuvOx was awarded the TechConnect Defense Innovation Award based on the potential impact the technology will have on national security.
Oct 11, 2017
NuvOx Pharma wins AZBio Fast Lane Award
NuvOx was honored with the AZBIO Fast Lane Award for the company's many achievements in the last 18 months.
Sep 29, 2017
National Cancer Institute Grants $3M to NuvOx Pharma for Phase II Clinical Trial in Brain Cancer
The NCI Grants $3M to NuvOx for a Phase II clinical trial in the brain cancer, glioblastoma.
May 19, 2017
NuvOx Wins MedCity INVEST Perfect Pitch Contest
NuvOx Pharma wins 1st place out of the biopharma companies at the MedCity INVEST Perfect Pitch Contest.
Mar 4, 2016
NuvOx wins Venture Madness competition and $60,000 prize.
NuvOx wins 1st place out of 113 entrants and a $60,000 cash prize.
bottom of page